Skip to main content

Table 1 Patient variables

From: Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection

 

Variable

Patientsα (n = 148)

Patientsβ (n = 43)

F = 0

n (%)

28 (18.92)

9 (20.93)

Male, n (%)

20 (71.4)

6 (66.7)

HBeAg positive, n (%)

28 (100)

9 (100)

ALT (median, IQR, U/L)

35.60 (17.27, 57.28)

19.60 (14.20, 42.37)

AST (median, IQR, U/L)

44.51 (30.99, 65.30)

37.40 (28.70, 54.77)

PLT (median, IQR, 109/L)

305.50 (257.75, 337.00)

310.00 (245.00, 345.50)

HBVDNA (median, IQR, IU/mL)

3.05 × 107 (7.71 × 106, 1.43 × 108)

3.11 × 107 (1.35 × 107, 2.03 × 108)

Age (median, IQR, year)

3.46 (2.60, 5.20)

3.83 (2.71, 5.04)

F = 1

n (%)

94 (63.51)

23 (53.49)

Male, n (%)

67 (71.3)

16 (69.6)

HBeAg positive, n (%)

87 (90.6)

21 (91.3)

ALT(median, IQR, U/L)

57.45 (30.93, 96.53)

60.10 (20.00, 89.90)

AST(median, IQR, U/L)

61.34 (42.39, 93.99)

62.10 (26.50, 100.27)

PLT (median, IQR, 109/L)

274.50 (229.75, 323.00)

282.00 (230.00, 326.00)

HBVDNA (median, IQR, IU/mL)

1.49 × 107 (2.56 × 106, 4.01 × 107)

7.60 × 106 (4.56 × 106, 3.00 × 107)

Age (median, IQR, year)

4.40 (2.98, 6.58)

5.83 (3.83, 9.00)

F = 2

n (%)

19 (12.84)

8 (18.60)

Male, n (%)

16 (84.2)

6 (75.0)

HBeAg positive, n (%)

16 (84.2)

7 (87.5)

ALT (median, IQR, U/L)

79.00 (52.60, 117.40)

75.40 (45.81, 106.87)

AST (median, IQR, U/L)

78.19 (43.10, 203.90)

77.95 (47.77, 106.87)

PLT (median, IQR, 109/L)

261.00 (226.00, 287.00)

272.50 (248.00, 414.50)

HBVDNA (median, IQR, IU/mL)

7.28 × 106 (9.51 × 105, 7.07 × 107)

7.28 × 106 (1.08 × 106, 1.11 × 107)

Age (median, IQR, year)

3.17 (2.00, 5.08)

4.41 (2.50, 5.33)

F = 3

n (%)

5 (3.38)

2 (4.65)

Male, n (%)

3 (60)

2 (100)

HBeAg positive, n (%)

4 (80)

2 (100)

ALT (median, IQR, U/L)

95.20 (60.65, 182.55)

79.50 (95.20)

AST (median, IQR, U/L)

105.30 (73.70, 290.95)

383.80 (105.30)

PLT (median, IQR, 109/L)

289.00 (214.50, 352.00)

289.00 (218.00)

HBVDNA (median, IQR, IU/mL)

4.96 × 106 (4.29 × 105, 5.86 × 107)

100.00 (4.96 × 106)

Age (median, IQR, year)

3.67(2.75, 8.16)

4.08 (3.25)

F = 4

n (%)

2 (1.35)

1 (2.33)

Male, n (%)

1 (50)

1 (100)

HBeAg positive, n (%)

1 (50)

0 (0)

ALT (median, IQR, U/L)

134.20 (324.24)

324.24

AST (median, IQR, U/L)

234.90 (548.33)

548.33

PLT (median, IQR, 109/L)

164 (217)

217

HBVDNA (median, IQR, IU/mL)

1.38 × 105(8.43 × 106)

8.43 × 106

Age (median, IQR, year)

1.42 (1.17)

1.17

  1. IQR inter-quartile range, ALT alanine aminotransferase, AST aspartate aminotransferase, ALP alkaline phosphatase, PLT platelet, HBeAg hepatitis B e-antigen
  2. α:Patients underwent liver stiffness measurement (LSM) by TE and liver biopsy
  3. β:Patients just underwent liver biopsy